Ridgefield-based Boehringer Ingelheim is being sued by a Florida man who claims the pharmaceutical company failed to provide a promised number of doses in its asthma inhalers.  Carl Ignacuinos alleges Boehringer Ingelheim marketed them as having 120 doses, but that the devices in some cases had half that many.  The Connecticut Law Tribune received an emailed statement from BI saying the company works diligently to ensure its medicines are manufactured in accordance with FDA-approved processes and dosing, and that the company is confident that its inhaler delivers the correct doses of the medicine.  The Plaintiff  is seeking class-action status for his complaint, without stating a precise amount in damages he is seeking.